EANS-News: Annual general meeting of Marseille-Kliniken AG resolves moderate dividend

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Subtitle: - Payout of a dividend of EUR 0.11 per share resolved -
Dividend payout ratio of 24 % does not negatively affect the Groups
further recovery - Conversion to registered shares increases
transparency

Annual & Special Corporate Meetings/Annual & Special Corporate
Meetings/Dividend payout approved

Hamburg (euro adhoc) - 03 December 2012 - The annual general meeting
of Marseille-Kliniken AG held today at it's headquarter in Hamburg
approved an application which was introduced by major shareholder
Ulrich Marseille about the payout of a dividend of EUR 0.11 per
share. All remaining applications introduced by the company's
administration were approved with high majority rates. The attending
shareholders represented approx. 68 percent of the share capital.

By the decision for the payout of a dividend with a ratio of 24
percent of the net income, the shareholders on the one hand
participate in the near term from the company's positive development
in the last business year 2011/2012. On the other hand the
disposition of most of the profit within the group raises the
potential for further improving the financial strength. The group
managed to more than double its earnings in the last business year as
well as in the first quarter of the new business year 2012/2013. This
makes the simultaneous payout of the dividend and the improvement of
the financial power possible.

Upon administration's application moreover a separate formal approval
of the directors who had been in place during last business year
2011/2012 took place. The majority of the participating shareholders
decided not to relieve former directors Dr. Thomas Klaue and Stefan
Herzberg. In contrast current chairman Michael Thanheiser such as
former CEO Ulrich Marseille were granted relief from the
shareholders.

Moreover resolved was a conversion from bearer to registered shares.
This resolution reflects the strategic reorientation and the internal
reorganisation which have been carried out by the company since
business year 2010/2011. The conversion to registered shares improves
the possibilities for communication with shareholders and thus
strengthens transparency.

Michael Thanheiser, chairman of Marseille-Kliniken AG, comments the
AGM's resolutions as follows: "Our shareholders have built the basis
for a more efficient communication with the company by their decision
for the conversion to registered shares. We can of course also
understand the shareholders' desire for a payout of a dividend,
although we had originally planned to carry forward the entire profit
to new account. Now we return to a shareholder friendly dividend
policy a little earlier, which is however realizable for us due to
the earnings and cash flow development. I therefore consider this
resolution of the AGM as a good decision." Dieter Wopen, who is newly
appointed as chairman since 15 November 2012, supplements: "The
opportunity of introducing me to the shareholders at the AGM was a
good start for my future activity for Marseille-Kliniken AG. I am
looking forward for a successful co-operation with Michael Thanheiser
and the complete management team."

Further inquiry note:
Hillermann Consulting
Jan Pahl
Investor Relations for Marseille-Kliniken AG
Poststraße 14-16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 3202791-0
www.marseille-kliniken.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Marseille-Kliniken AG
Alte Jakobstraße 79/80
D-10179 Berlin
phone: +49 (0)30 246 32-400
FAX: +49 (0)30 246 32-401
mail: info@marseille-kliniken.de
WWW: http://www.marseille-kliniken.de
sector: Pharmaceuticals
ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
Hamburg, regulated dealing/prime standard: Frankfurt
language: English